Immunocore (ADR) (IMCR)
Develops ImmTAX-based immunotherapies and sells KIMMTRAK for eligible uveal melanoma patients.
$31.23
vs last close−1.19 (−3.68%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.16
Revenue estimate
$152.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.47$0.10−$0.20$0.02−$0.60$0.25−$0.02Pending
Estimate−$0.31−$0.35−$0.21−$0.30−$0.28−$0.26−$0.01−$0.16
Surprise−51.6%+128.6%+4.8%+105.2%−114.3%+196.2%−100.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$105.2M$121.5M$134.3M$103.7M$140.1M$145.0M$115.9MPending
Estimate$85.5M$121.8M$134.2M$142.2M$144.5M$145.4M$148.8M$152.6M
Surprise+23.0%−0.3%+0.1%−27.1%−3.1%−0.3%−22.1%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.07 | — | — |
| Sep 2027 | −$0.01 | — | — |
| Jun 2027 | −$0.07 | — | — |
| Mar 2027 | −$0.09 | — | — |
| Dec 2026 | −$0.18 | — | — |
| Nov 2026 | −$0.16 | — | — |
| Aug 2026 | −$0.01 | −$0.02 | −100.0% |
| May 2026 | −$0.26 | $0.25 | +196.2% |
| Feb 2026 | −$0.28 | −$0.60 | −114.3% |
| Nov 2025 | −$0.30 | $0.02 | +105.2% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.07 | — | — | $134.8M | — | — | — |
| Sep 2027 | −$0.01 | — | — | $128.3M | — | — | — |
| Jun 2027 | −$0.07 | — | — | $124.4M | — | — | — |
| Mar 2027 | −$0.09 | — | — | $121.2M | — | — | — |
| Dec 2026 | −$0.18 | — | — | $116.1M | — | — | — |
| Nov 5, 2026 | −$0.16 | — | — | $152.6M | — | — | — |
| Aug 6, 2026 | −$0.01 | −$0.02 | −100.0% | $148.8M | $115.9M | −22.1% | +3.6% |
| May 6, 2026 | −$0.26 | $0.25 | +196.2% | $145.4M | $145.0M | −0.3% | +6.6% |
| Feb 25, 2026 | −$0.28 | −$0.60 | −114.3% | $144.5M | $140.1M | −3.1% | −4.5% |
| Nov 6, 2025 | −$0.30 | $0.02 | +105.2% | $142.2M | $103.7M | −27.1% | +2.6% |
| Aug 7, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 1, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 3, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Jan 15, 2021 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 |